> Chronic conditions
> Dr Michael ROSENBLATT
Chief Medical Officer, Flagship Pioneering, Cambridge, MA
> Jessica Grossman, MD
> Ponda Motsepe – Ditshego, MD
Executive Medical Director, Amgen Bone
> Cen Xu, PhD
Executive Director, Amgen Neuroscience
> Eric M Pearlman
Senior Medical Director-Neuroscience, US Medical Affairs, Eli Lilly and Company
> Dan Cua, Ph.D.
Vice President IL-23 Pathway Area Leader for the Immunology Therapeutic Area, Janssen Biotech, Inc.
> Dr. Mads Frederik Rasmussen
Corporate Project Vice President (CPVP) for GLP-1, CV and Outcomes, Novo Nordisk A/S
> Marcella Ruddy
Strategic Program Direction, Immunology and Inflammation, Regeneron Pharmaceuticals, Inc.